Canadian Heritage committee  At Innovation, Science and Economic Development Canada, one of the tenets of the inclusive innovation agenda was the adaptation to the digital world, recognizing that a huge piece of the economy of the future, the modern economy, will be in this new world of Internet of things an

Canadian Heritage committee  I'll start at the policy level on the diversity of voices piece. With respect to the specific aspect of diversity of voices, as my colleagues from the bureau have indicated, it's not in their act to necessarily look at transactions within that lens. There are aspects of diversit

International Trade committee  I'll actually turn to my other colleague on that.

International Trade committee  Mr. Chair, in the balance of the agreement, on the pharmaceutical provisions and the intellectual property provisions, there were elements that were specifically in the CETA text, and then there were portions that were fundamental to the balance we struck for the Canadian impleme

International Trade committee  Our view, in consulting and meeting with stakeholders, is that these powers are required for the regulation-making power that we believe is necessary for effective appeal rights, and in consequence, for the ending of dual litigation. It's fair to say that, as you indicated, this

International Trade committee  The intent is to ensure that we've actually given ourselves the authority so that parties cannot potentially use this provision to suggest that we don't have the regulation-making authority to move forward.

International Trade committee  We've engaged with stakeholders of every nature in the pharmaceutical industry, including the Canadian Generic Pharmaceutical Association, in trying to ensure that we get the balance right and can implement effectively.

International Trade committee  In consultation with stakeholders, with respect to section 62, there has been previous action to repeal this clause. We have come to the conclusion, following our consideration, that a portion of it is useful to us and is necessary. The coordinating amendment is in line with draf

International Trade committee  A wide range of estimates has been provided on the potential costs of pharmaceutical changes under the intellectual property provisions of the act. There has been a number of those sets of analyses. It's extremely difficult work. In fact, we don't believe the estimates we would b

International Trade committee  It's not a study. It's data. I can't speak to what the PBO has in their possession. I can say, from our perspective as the department responsible for the intellectual property statutes, that in our assessment, based on what we see as the changes to the intellectual property statu

Industry committee  Perhaps I can jump in here to indicate that in fact Bill C-25 actually goes an explicit step further. Currently, under securities commissions' laws in eight of the securities commissions in the country, corporations on an annual basis already need to file the gender makeup of t

Industry committee  What the bill does is facilitate a conversation between shareholders and the corporation. The acceptability would be up to the shareholders. On an annual basis, they'd have the opportunity to make representations to their firm and to indicate whether this diversity policy was suf

Industry committee  Our view is that shareholders are best placed to advocate within their organizations, and our minister has made it clear that should there be a lack of progress on diversity within the corporate structure—

Industry committee  Well, it varies. As my colleague has indicated, diversity is a broad concept that includes gender, race, geography, class, age. I think each corporation will work with shareholders to determine what makes the most sense for them in their line of business.

Industry committee  We would certainly hope that indigenous persons were one of the very elements that corporations would look to—